These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 15003079

  • 1. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [Abstract] [Full Text] [Related]

  • 2. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.
    Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.
    J Clin Psychiatry; 2011 Jul; 72(7):962-9. PubMed ID: 21034693
    [Abstract] [Full Text] [Related]

  • 3. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM, Brown EB, Gonzales JS, Munir R.
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 5. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency.
    Tome MB, Isaac MT, Harte R, Holland C.
    Int Clin Psychopharmacol; 1997 Mar; 12(2):81-9. PubMed ID: 9219043
    [Abstract] [Full Text] [Related]

  • 6. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of controlled-release paroxetine in the treatment of late-life depression.
    Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.
    J Clin Psychiatry; 2003 Sep; 64(9):1065-74. PubMed ID: 14628982
    [Abstract] [Full Text] [Related]

  • 8. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J.
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [Abstract] [Full Text] [Related]

  • 9. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
    Mowla A, Kardeh E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):970-3. PubMed ID: 21291943
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M, Vandoolaeghe E, Desnyder R.
    J Affect Disord; 1996 Dec 16; 41(3):201-10. PubMed ID: 8988452
    [Abstract] [Full Text] [Related]

  • 11. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y, Cao X, Zang W, Tan S, Ou CQ, Shen X, Gao T, Zhao L.
    Trials; 2019 Jan 09; 20(1):34. PubMed ID: 30626424
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct 09; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 13. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
    Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 2004 Feb 09; 65(2):217-21. PubMed ID: 15003076
    [Abstract] [Full Text] [Related]

  • 14. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.
    Encephale; 2003 Feb 09; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [Abstract] [Full Text] [Related]

  • 15. Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients.
    Räsänen P, Hakko H, Tiihonen J.
    J Clin Psychopharmacol; 1999 Aug 09; 19(4):297-302. PubMed ID: 10440455
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB, Cloninger CR, Watson JP, Isaac MT.
    J Affect Disord; 1997 Jul 09; 44(2-3):101-9. PubMed ID: 9241570
    [Abstract] [Full Text] [Related]

  • 17. Phenytoin as an augmentation for SSRI failures: a small controlled study.
    Shapira B, Nemets B, Trachtenberg A, Belmaker RH.
    J Affect Disord; 2006 Nov 09; 96(1-2):123-6. PubMed ID: 16814397
    [Abstract] [Full Text] [Related]

  • 18. Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Liu Y, Zhou X, Zhu D, Chen J, Qin B, Zhang Y, Wang X, Yang D, Meng H, Luo Q, Xie P.
    Hum Psychopharmacol; 2015 May 09; 30(3):132-42. PubMed ID: 25689398
    [Abstract] [Full Text] [Related]

  • 19. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.
    Int Clin Psychopharmacol; 2010 Jul 09; 25(4):189-98. PubMed ID: 20531012
    [Abstract] [Full Text] [Related]

  • 20. L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
    Łojko D, Rybakowski JK.
    J Affect Disord; 2007 Nov 09; 103(1-3):253-6. PubMed ID: 17289154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.